By InvitationNot Applicable

GLP_1 RA Ultrasound Study

United States100 participantsStarted 2024-07-08

Plain-language summary

The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.

Who can participate

Age range10 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Body Mass Index over 35 * Type 2 Diabetes * Currently taking GLP01 RA agonist (for GLP 1 group) * Not taking GLP-1 RA agonist (for control group) Exclusion Criteria: * Diagnosis of gastroparesis * patient refusal to participate * Previous gastric bypass or any other gastric surgery * Currently on peritoneal dialysis * Abdominal pathology * Gastro-intestinal obstruction * Pregnancy

What they're measuring

Aspiration Risk determined by POGUS

Timeframe: Two years

Trial details

NCT IDNCT06581120

SponsorChildren's Hospital Medical Center, Cincinnati

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07

View on ClinicalTrials.gov More Glucagon Like Peptide-1 (GLP-1 trials